|

DB-1305/BNT325 Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: DB-1305/BNT325 for Injection

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • DualityBio Inc.2

Indications

  • Cancer2
  • Liver Disease1
  • Solid Tumors1
  • Advanced Solid Tumor1
  • Liver Cancer1

Cerritos, California1 trial

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Site 103

Phase 1/2

Los Angeles, California1 trial

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA06-0

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.